An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...

UCSF scientists discover how cancer cells hijack the protein factory of the cell to churn out MYC protein, the driver of 70% ...

The growth protein, MYC, was consistently found with RBM42, which spurs MYC production, in human pancreatic tumors. Above, microscopy for MYC (red ...

Apparently, the biopsy could not be taken because the ... but I would like for all GPs to be aware of the symptoms of pancreatic cancer and to know that jaundice is not the only sign.

These pancreatic lesions ... genetic predispositions, and cancer-specific biomarkers. Liquid biopsy is promising for screening, especially in asymptomatic individuals, as it opens the possibility ...

Comparison of mutational landscape in primary and metastatic pancreatic tumors. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not include a ...

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...

Solid areas may contain atypical cells or invasive cancer and extensive sampling of the specimen once ... If the diagnosis cannot be confirmed preoperatively, laparoscopic exploration and biopsy is ...